Contrastingly, for triple-negative breast cancer (TNBC), the phenotype EGFR was the best predictor at 0.78 followed by CDKN2A at 0.75 (Supplemental Figure S3). The gene discussed is EGFR; the disease is triple-negative breast carcinoma.